Klaus Klinder

560 total citations
15 papers, 419 citations indexed

About

Klaus Klinder is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Klaus Klinder has authored 15 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Klaus Klinder's work include Neuroscience and Neuropharmacology Research (4 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Klaus Klinder is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Klaus Klinder collaborates with scholars based in Germany, United States and Switzerland. Klaus Klinder's co-authors include Thomas Weiser, Wolfram Gaida, Kirsten Arndt, Gisela Skopp, Yunhai Cui, Achim Sauer, R. Aderjan, Albert C. Ludolph, Frank Gillardon and Bastian Hengerer and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Neuropharmacology and Molecular Pharmaceutics.

In The Last Decade

Klaus Klinder

15 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus Klinder Germany 13 143 90 89 61 55 15 419
J. M. Gubbens‐Stibbe Netherlands 12 125 0.9× 33 0.4× 120 1.3× 59 1.0× 60 1.1× 16 483
Pál Kocsis Hungary 10 145 1.0× 103 1.1× 112 1.3× 22 0.4× 49 0.9× 21 430
Mario Vertechy Italy 8 105 0.7× 176 2.0× 104 1.2× 41 0.7× 69 1.3× 11 374
M.W.E. Langemeijer Netherlands 12 134 0.9× 38 0.4× 106 1.2× 18 0.3× 47 0.9× 21 396
Filomena Lauro Italy 13 201 1.4× 263 2.9× 88 1.0× 32 0.5× 49 0.9× 20 568
Dan Cheng China 13 185 1.3× 80 0.9× 52 0.6× 15 0.2× 69 1.3× 27 502
Letizia Antonilli Italy 13 110 0.8× 86 1.0× 181 2.0× 17 0.3× 95 1.7× 25 565
S. W. Gumułka Poland 13 199 1.4× 171 1.9× 238 2.7× 19 0.3× 52 0.9× 35 496
M. Marietta United States 12 110 0.8× 55 0.6× 93 1.0× 14 0.2× 104 1.9× 22 481
Concetta Dagostino Italy 13 185 1.3× 389 4.3× 138 1.6× 28 0.5× 112 2.0× 19 742

Countries citing papers authored by Klaus Klinder

Since Specialization
Citations

This map shows the geographic impact of Klaus Klinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Klinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Klinder more than expected).

Fields of papers citing papers by Klaus Klinder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Klinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Klinder. The network helps show where Klaus Klinder may publish in the future.

Co-authorship network of co-authors of Klaus Klinder

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Klinder. A scholar is included among the top collaborators of Klaus Klinder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Klinder. Klaus Klinder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Sommer, Susanne, Hannes Sigrist, Eliza Koroś, et al.. (2022). Effects of GPR139 agonism on effort expenditure for food reward in rodent models: Evidence for pro-motivational actions. Neuropharmacology. 213. 109078–109078. 12 indexed citations
2.
Cui, Yunhai, et al.. (2021). A Bidirectional Permeability Assay for beyond Rule of 5 Compounds. Pharmaceutics. 13(8). 1146–1146. 20 indexed citations
3.
Schnapp, Gisela, Heike Neubauer, Frank Büttner, et al.. (2020). A small-molecule inhibitor of lectin-like oxidized LDL receptor-1 acts by stabilizing an inactive receptor tetramer state. Communications Chemistry. 3(1). 75–75. 17 indexed citations
5.
Bretschneider, Tom, Andreas H. Luippold, Helmut Romig, et al.. (2017). Ultrafast and Predictive Mass Spectrometry–Based Autotaxin Assays for Label-Free Potency Screening. SLAS DISCOVERY. 22(4). 425–432. 13 indexed citations
6.
Sakamoto, Atsushi, Holger Fuchs, Naoki Ishiguro, et al.. (2017). Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates. Molecular Pharmaceutics. 14(10). 3436–3447. 44 indexed citations
7.
Danzeisen, Ruth, Frank Gillardon, Erich Buerger, et al.. (2005). Targeted Antioxidative and Neuroprotective Properties of the Dopamine Agonist Pramipexole and Its Nondopaminergic Enantiomer SND919CL2x [(+)2-Amino-4,5,6,7-tetrahydro-6-lpropylamino-benzathiazole Dihydrochloride]. Journal of Pharmacology and Experimental Therapeutics. 316(1). 189–199. 90 indexed citations
8.
Gaida, Wolfram, Klaus Klinder, Kirsten Arndt, & Thomas Weiser. (2005). Ambroxol, a Nav1.8-preferring Na+ channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain. Neuropharmacology. 49(8). 1220–1227. 75 indexed citations
9.
Schmidt, Harald, Stefan Viktor Vormfelde, Klaus Klinder, et al.. (2003). The role of active metabolites in dihydrocodeine effects. International Journal of Clinical Pharmacology and Therapeutics. 41(3). 95–106. 30 indexed citations
10.
Buccafusco, Jerry J., Thomas Weiser, Karin Winter, Klaus Klinder, & Alvin V. Terry. (2003). The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys. Neuropharmacology. 46(1). 10–22. 33 indexed citations
11.
Schmidt, Helmut, Stefan Viktor Vormfelde, Klaus Klinder, et al.. (2002). Affinities of Dihydrocodeine and its Metabolites to Opioid Receptors. Pharmacology & Toxicology. 91(2). 57–63. 31 indexed citations
12.
Skopp, Gisela, Lucia Pötsch, Klaus Klinder, et al.. (2001). Saliva testing after single and chronic administration of dihydrocodeine. International Journal of Legal Medicine. 114(3). 133–140. 12 indexed citations
13.
Klinder, Klaus, Gisela Skopp, R. Mattern, & R. Aderjan. (1999). The detection of dihydrocodeine and its main metabolites in cases of fatal overdose. International Journal of Legal Medicine. 112(3). 155–158. 9 indexed citations
14.
Skopp, Gisela, Klaus Klinder, Lucia Pötsch, et al.. (1998). Postmortem distribution of dihydrocodeine and metabolites in a fatal case of dihydrocodeine intoxication. Forensic Science International. 95(2). 99–107. 15 indexed citations
15.
Skopp, Gisela, Rainer Lutz, Lucia Pötsch, et al.. (1997). An In Vitro Experiment for Postmortem Vascular Permeation. The Passage of Morphine and Morphine Glucuronides Across a Vascular Wall. Journal of Forensic Sciences. 42(3). 486–491. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026